• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.11%

    Allergan Inc. (AGN)

    -NYSE
    307.00 Up 0.30(0.10%) 4:03PM EDT
    |After Hours : 306.94 Down 0.06 (0.02%) 7:44PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 7,237,900   6,300,400   5,646,600  
    Cost of Revenue842,400  795,800  751,200  
    Gross Profit 6,395,500   5,504,600   4,895,400  
    Operating Expenses
    Research Development1,191,600  1,042,300  977,300  
    Selling General and Administrative2,837,200  2,519,400  2,193,100  
    Non Recurring245,000  16,900  23,800  
    Others112,400  116,700  90,200  
    Total Operating Expenses4,386,200  3,695,300  3,284,400  
    Operating Income or Loss 2,009,300   1,809,300   1,611,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net49,400  (3,500)(16,400)
    Earnings Before Interest And Taxes2,058,700  1,805,800  1,594,600  
    Interest Expense69,400  75,000  63,600  
    Income Before Tax1,989,300  1,730,800  1,531,000  
    Income Tax Expense456,700  458,300  430,300  
    Minority Interest(4,600)(3,600)(3,700)
    Net Income From Continuing Ops1,532,600  1,272,500  1,100,700  
    Non-recurring Events
    Discontinued Operations(3,800)(283,800)1,800  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 1,524,200   985,100   1,098,800  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 1,524,200   985,100   1,098,800  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.